Parity as predictor of early hypertension during menopausal transition by Giubertoni, E et al.
Copyright © Lippincott Williams & Wilkins. Unauthorized reproduction of this article is prohibited.
Parity as predictor of early hypertension during
menopausal transition
Elisa Giubertoni, Luca Bertelli, Ylenia Bartolacelli, Giorgia Origliani, and Maria G. Modena
Objectives: Studies regarding the effects of parity on
blood pressure in later life produced conflicting results. The
aim of our study is to analyse whether parity influences
the prevalence of hypertension in perimenopausal and
postmenopausal women.
Methods: One thousand perimenopausal and
postmenopausal women (mean age 55.2!5.4 years) were
enrolled with a median follow-up of 63.0 months. The
study sample consisted of patients who self-referred, in
1998–2009, to the BenEssere Donna Clinic, dedicated to
menopause-related disorders.
Results: One hundred and twenty-two (12.2%) women
were nulliparous and 878 (87.8%) had at least one child.
Thirty-four (27.9%) women among nulliparous and 326
(37.1%) among parous were hypertensive at baseline
(P¼0.046) and 812 women (81.2%) were in their
postmenopausal period. Univariate analysis showed that
women with one or more children were at higher risk of
being hypertensive [odds ratio (OR): 1.529; 95%
confidence interval (CI): 1.006–2.324; P¼ 0.047]. Likewise,
multivariate analysis revealed that parity (OR: 2.907; 95%
CI: 1.290–6.547; P¼0.010), BMI (OR: 1.097; 95% CI:
1.048–1.149; P<0.001) and family history of
hypertension (OR: 3.623; 95% CI: 2.231–5.883;
P<0.001) were independently related to hypertension at
baseline. In a subanalysis of 640 initially normotensive
women, 109 (17.0%) patients developed hypertension
after follow-up, without a statistically significant
association with parity (13.6% in nulliparous versus 17.6%
in parous; P¼0.362). Consistently, parity showed no
relationship with the incidence of hypertension during
follow-up (OR: 1.350; 95% CI: 0.707–2.579; P¼0.363).
Conclusion: For the first time in a population of White
perimenopausal and postmenopausal women, parity was
demonstrated to be independently associated with early
hypertension during menopausal transition. Conversely,
postmenopausal hypertension was not related with parity.
Keywords: early hypertension, menopausal transition,
parity, white women
Abbreviations: CI, confidence interval; CVD,
cardiovascular disease; DXA, dual-emission X-ray
absorptiometry; HDL, high density lipoprotein; HRT,
hormonal replacement therapy; LDL, low density
lipoprotein; NO, nitric oxide; OR, odds ratio
INTRODUCTION
Hypertension is the most common cardiovascularrisk factor for women [1] and both SBP and DBPare continuously and independently related to
cardiovascular morbidity and mortality [2]. Blood pressure
is affected by a number of traditional cardiovascular risk
factors such as age, family history and BMI, but also those
parameters related to reproductive history may play a role
in hypertension development [3]. Pregnancy produces
marked alterations in vascular physiology [4–6] and may
be considered as a temporary dip into the metabolic syn-
drome [7]. It may result in permanent and not just temporary
detrimental effects on the body and promote weight gain,
insulin resistance and dyslipidemia in later life [8,9]. Hemo-
dynamic adaptations during pregnancy include increases in
cardiac output and blood volume and decreases in per-
fusion pressure and total systemic vascular resistance [4].
Several studies have considered the association between
parity and the prevalence of hypertension in later life and
results were conflicting [3,4,10,11]. One study reported
significant effects of parity on decreases in both SBP and
DBP [12], whereas other studies showed no significant
association or a clinically small negative relationship
between reproductive history and blood pressure or hy-
pertension [10,11,13,14]. Additionally, some studies
suggested a protective effect of parity only for younger
subgroups of women [10]. Conversely, a study conducted
on 126 African–American women demonstrated that as
parity increased, SBP increased; however, DBP decreased
after three to four children [3]. Similarly, the Trabzon
Hypertension Study demonstrated a linear association
between parity and the prevalence of hypertension [15].
Finally, considering the association of multiparity with
increased BMI in later life [14], it is plausible to hypothesize
a relationship between multiparity and hypertension.
The aim of our study is, therefore, to investigate such
relationship between parity and hypertension for the first
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time in a population of perimenopausal and postmeno-
pausal women. In addition, our purpose is to analyze the
role of parity and compare it with traditional cardiovascular
risk factors, such as BMI, family history, dyslipidaemia,
previous oral contraceptive use and age at menopause.
METHODS
Population
We retrospectively enrolled all women who presented at
the BenEssere Donna Clinic from 1998 to 2011, who
reached at least 2 years of follow up in the period from
October 2009 to April 2011.
Therefore, we obtained a homogenous and representa-
tive sample of white perimenopausal and postmenopausal
women. All participants gave their written informed con-
sent to participate in this study and for the processing of
personal data. The study protocol was approved from our
internal research board.
Study protocol and data collection
We collected personal and anthropometric data of all
women and performed a clinical examination, including
a 12-lead electrocardiogram. The questionnaire consisted
of questions regarding family history (for hypertension,
diabetes and cardiovascular disease), clinical history, repro-
ductive life (menarche, menopause, parity and miscar-
riages) and current drug therapy. In order to allow an
adequate cardiovascular risk assessment, women were
requested to have recent blood tests containing high
density lipoprotein (HDL) cholesterol, low density lipopro-
tein (LDL) cholesterol, triglycerides and glycemia. After
anamnestic and clinical evaluation, the cardiologist gave
advice regarding lifestyle modifications and prescribed a
pharmacologic therapy when indicated. Also bone mineral
density, measuredwith dual-emission X-ray absorptiometry
(DXA), and information about use of vitamin D/calcium
supplements or bisphosphonates were collected.
Follow-up
All patients were followed up in our outpatient clinic with a
clinical examination after at least 2 years. In addition, a
telephone interview was done for those patients who failed
to present during follow-up in the clinic. Events recorded
were incidence of hypertension, hypertensive urgencies
and emergencies, myocardial infarction, angina pectoris,
transient ischemic attack, stroke, paroxysmal atrial fibrilla-
tion, and all other heart diseases that required cardiac
surgery.
BenEssere Donna Clinic
The BenEssere Donna Clinic can be considered as the first
example of a women’s clinic in Italy and it is dedicated to
the study, prevention and treatment of cardiovascular men-
opause-related disorders. Since 1996, this service is open to
all perimenopausal and postmenopausal women up to
65 years. Women are initially drawn to the clinic through
local media advertising, have free access and can make
queries about particular symptoms by taking appointments
beforehand. The interconnection with other institutions
and services of the hospital makes the BenEssere Donna
a multidisciplinary center dedicated to the identification of
key risk factors that arise especially in the postmenopausal
period. For example, women at high cardiovascular risk or
with metabolic syndrome can be addressed to the cardio-
metabolic clinic or to further investigation. These prefer-
ential pathways ensure a targeted and complete assessment
of the women.
Definitions
Family history of hypertension or diabetes was defined as
the presence of hypertension or diabetes diagnosis,
respectively, in parents, brothers or sisters, sons or daugh-
ters of the patient. Family history for cardiovascular disease
was considered positive only when a cardiovascular event
occurred in a first-degree relative younger than 56 years old
if man and younger than 66 years old if woman [16].
Hypertension was defined through serial blood pressure
measurements and in accordance with current guidelines
[17–20].
Natural menopause was defined as the permanent ces-
sation of menses as a result of the loss of ovarian follicular
activity. It was diagnosed retrospectively after 12 consecu-
tive months of amenorrhea, for which there were no other
pathological of physiological cause [21]. Induced meno-
pause was defined as the cessation of menstruation, which
follows either surgical removals of both ovaries (with or
without hysterectomy) or iatrogenic ablation of ovarian
function, for example, by chemotherapy or radiation [21].
According to the Staging of Reproductive Aging Workshop
Staging System, the perimenopausal period was divided
into early and late menopausal transition. Early menopausal
transition begins when cycles remain regular, but their
length changes by 7 day or more and the late perimeno-
pausal transition ends 1 year after menopause [22].
The diagnosis of diabetes was made in accordance to
the recommendations of American Diabetes Association
[23,24].
In order to define the presence of the metabolic syn-
drome, we adopted the criteria of the American Association
of Clinical Endocrinologists [25].
Statistical analysis
We compared two cohorts of patients based on parity
(nulliparous women versus women with at least one child).
Continuous data are reported as mean! SD unless other-
wise specified. Categorical data are presented as absolute
values and percentages. Comparison of continuous vari-
ables was performed by the use of Student’s t-test or
Kruskal–Wallis test in case of nonnormal distribution.
Levene test was performed for testing equality of variances.
Either Pearson x2 test or Fisher’s exact test were used as
appropriate for comparison of categorical variables.
Variables predictive of events were calculated through
univariate analysis by logistic regression and presented
with odds ratios (OR) and 95% confidence intervals (CI).
Moreover, data were adjusted through a backward stepwise
logistic regression.
All tests were two-tailed, and probability was considered
to be statistically significant at 0.05. All analyses were
performed using SPSS software, version 18.0 for Windows
(SPSS Inc., Chicago, Illinois, USA) and STATA/SE software,
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version 10.0 for Windows (STATA Corp., College Station,
Texas, USA).
The authors had full access to and take full responsibility
for the integrity of the data. All authors have read and agree
to the manuscript as written.
RESULTS
The study population consisted of 1000 patients, with a
mean age of 55.2! 5.4 years. Mean age at menarche
resulted 12.3! 1.9 years; the number of deliveries was
1.45! 0.85 and the number of miscarriages 0.38! 0.75.
Eight hundred and twelve (81.2%) women were in
postmenopausal status at baseline (mean age at menopause
49.5! 4.6 years), whereas 188 (18.8%) patients were in their
premenopausal period. Of these 188 (fertile) premeno-
pausal women, 167 (88.8%) experienced menopause
during follow-up; thus, at the second examination 979
(97.9%) women were in postmenopausal status (mean
age at menopause 49.7! 4.6 years) and 21 (2.1%) in
premenopause. One hundred and one (10.3%) of these
979 postmenopausal women experienced an induced
menopause.
Three hundred and sixty (36.0%) patients presented at
the BenEssere Donna Clinic with a history of hypertension,
diagnosed at a mean age of 50.7! 8.4 years, whereas 109
(10.9%) developed hypertension during follow-up.
Twenty-one (2.1%) patients had a diagnosis of hyper-
tension at baseline, but after lifestyle modifications and
increased physical activity, reported normal blood pressure
at the end of follow-up. The prevalence of hypertension in
our population was, therefore, 44.8%, diagnosed at a mean
age of 52.6! 8.4 years. The median follow-up period was
63.0 months (25–758 percentiles: 42.7–104.0 months).
The study population was divided into two groups,
according to parity. One hundred and twenty two
(12.2%) women were nulliparous and 878 (87.8%) have
had at least one child. Basal characteristics did not differ
between the two groups. Conversely, the prevalence of
hypertension was significantly higher among parous
women: 34 (27.9%) nulliparous versus 326 (37.1%) parous
women resulted hypertensive at baseline (P¼ 0.046). More-
over, 107 (87.7%) among nulliparous and 705 (80.3%)
among parous women were in their postmenopausal
period at baseline (P¼ 0.050) and consistently, nulliparous
women showed younger age at menopause (47.6! 5.3
versus 49.7! 4.4; P< 0.001). Comparisons between groups
are shown in Tables 1 and 2.
Univariate analysis confirmed the relationship between
parity and hypertension, pointing out that parous women
had a statistically significant increase of estimated risk of
hypertension at baseline (OR: 1.529; 95% CI: 1.006–2.324;
P¼ 0.047). As expected, results showed that age (OR: 1.040;
95% CI: 1.015–1.065; P¼ 0.001), weight (OR: 1.043; 95% CI:
1.032–1.054; P< 0.001), BMI (1.129; 95% CI: 1.097–1.163;
P< 0.001) and diabetes (OR: 2.360; 95% CI: 1.024–5.438;
P¼ 0.044) were related to hypertension at baseline. Meta-
bolic syndrome (OR: 19.764; 95% CI: 11.429–34.178;
P< 0.001) and family history of hypertension (OR: 2.848;
95% CI: 2.120–3.826; P< 0.001) appeared to have the
strongest associations with hypertension. Conversely, no
relation was evidenced between hypertension and
TABLE 1. Basal parameters of subgroups according to parity
Parameter Nulliparous N¼122 Parous N¼878 P
Personal and anthropometric data
Age (years) 54.5!5.6 55.3!5.4 0.102
BMI (kg/m2) 26.0!5.3 26.3!4.7 0.438
Reproductive history and menopause
Age at menarche (years) 12.2!1.8 12.3!2.0 0.358
Miscarriages 0.4!0.9 0.4!0.7 0.336
Menopause 107 (87.7%) 705 (80.3%) 0.050
Induced menopause 18 (16.8%) 83 (11.8%) 0.140
Age at menopause (years) 47.6!5.3 49.7!4.4 <0.001
OC 59 (48.4%) 407 (46.4) 0.677
OC (months) 62.5!71.1 52.0!61.6 0.234
HRT 47 (43.9%) 296 (42.0%) 0.705
HRT (months) 61.5!46.4 62.5!50.6 0.894
Cardiovascular risk assessment
Framingham risk score (%) 2.3!0.3 2.6!0.1 0.320
Family history
Family history of CVD 28 (23.0%) 215 (24.5%) 0.711
Family history of diabetes 46 (37.7%) 290 (33.0%) 0.306
Family history of hypertension 77 (63.1%) 563 (64.1%) 0.828
Modifiable risk factors
Smoking status 25 (20.5%) 152 (17.3%) 0.389
Total cholesterol (mg/dl) 226.0!38.4 227.8!39.9 0.664
HDL cholesterol (mg/dl) 64.9!20.3 62.5!14.9 0.308
LDL cholesterol (mg/dl) 145.3!38.3 146.6!36.8 0.776
Triglycerides (mg/dl) 98.5!51.1 104.3!54.6 0.319
Blood glucose (mg/dl) 93.1!12.5 94.1!17.4 0.560
Diabetes 2 (1.6%) 21 (2.4%) 0.603
CVD, cardiovascular disease; HDL, high density lipoprotein; HRT, hormone replacement therapy; LDL, low density lipoprotein; OC, oral contraceptive. Parameters are expressed as mean
value!1 SD or as percentages.
Parity predicts hypertension
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menopause (P¼ 0.777) or hormone replacement therapy
(P¼ 0.282). On the contrary, LDL/HDL ratio (OR: 1.423;
95% CI: 1.202–1.684; P< 0.001), triglycerides (OR: 1.009;
95% CI: 1.006–1.012; P< 0.001) and blood glucose (OR:
1.017; 95% CI: 1.006–1.027; P¼ 0.001) were related to
hypertension. Finally, as expected, the higher Framingham
Risk Score, the higher risk of being hypertensive. Results are
shown in Table 3.
Backward multivariate logistic regression analysis con-
firmed results with regard to parity, indeed it showed an
independent association with hypertension (OR: 2.907;
95% CI: 1.290–6.547; P¼ 0.010), even stronger compared
with the univariate. Consistently, metabolic syndrome (OR:
17.252; 95% CI: 7.057–42.178; P< 0.001) and family history
of hypertension (OR: 3.623; 95% CI: 2.231–5.883; P< 0.001)
remained the strongest predictors of being hypertensive at
baseline. Results are shown in Table 4 and Fig. 1.
Comparisons between groups according to parity
revealed that parous women had higher prevalence of
hypertension not only at baseline, but also after follow
up: 404 (46.0%) women among parous versus 44 (36.1%)
women among nulliparous were hypertensive after follow-
up. Despite this, the incidence of hypertension did not
differ between groups (P¼ 0.687). Results are shown in
Table 2.
Prospective analysis
We performed a subanalysis of our population, considering
640 initially normotensive women, stratified for parity into
two groups. Eighty-eight (13.8%) women were nulliparous
and 552 (86.2%) have had at least one child. Basal charac-
teristics did not differ between nulliparous and parous
women, respectively, with the exception of age
(53.7! 5.0 versus 55.0! 5.3; P¼ 0.030), menopause [78
(88.6%) versus 440 (79.7%); P¼ 0.048] and age at meno-
pause (47.9! 4.6 versus 49.5! 4.4; P¼ 0.003).
Analysing the incidence of hypertension during follow-
up within these groups, there were no differences with
regard to parity (P¼ 0.362). Results are shown in Table 2.
At univariate analysis parity did not show any association
with the incidence of hypertension during follow-up (OR:
1.350; 95% CI: 0.707–2.579; P¼ 0.363). Conversely, BMI
(OR: 1.074; 95% CI: 1.027–1.124; P¼ 0.002), family history
of hypertension (OR: 1.667; 95% CI: 1.083–2.567; P¼ 0.020)
and Framingham-risk score at baseline (OR: 1.183; 95% CI:
1.016–1.378; P¼ 0.030) resulted related with the incidence
of hypertension during follow-up.
Finally, after backward stepwise adjustment, parity was
excluded from being a significant predictor of hyperten-
sion. Results of multivariate analysis are shown in Table 5.
Those parameters associated with the incidence of hyper-
tension during follow-up were age (OR: 1.067; 95% CI:
1.012–1.125; P¼ 0.016), BMI (OR: 1.090; 95% CI: 1.027–
1.158; P¼ 0.005) and family history of hypertension (OR:
2.193; 95% CI: 1.208–3.979; P¼ 0.010), as well as total (OR:
1.039; 95% CI: 1.013–1.067; P¼ 0.003), HDL (OR: 0.970;
95% CI: 0.944–0.996 P¼ 0.026) and LDL cholesterol (OR:
0.963; 95% CI: 0.938–0.990; P¼ 0.007).
DISCUSSION
Our study, for the first time in a population of white
perimenopausal and postmenopausal women, demon-
strated the association of parity with early hypertension
during menopausal transition; particularly, women with at
least one child had almost three-fold risk of being hyper-
tensive comparedwith nulliparous women. Conversely, the
incidence of hypertension during follow-up was not related
with parity, so that the influence of parity seemed to play its
role within perimenopause and not after menopause.
Our results are consistent with other studies indicating a
linear association between parity and the prevalence of
hypertension [15] or showing increased SBP with increased
parity [3]; conversely, Gunderson et al. [4] stated that a first
birth may be accompanied by persistent lower levels of
TABLE 2. Prevalence of hypertension at baseline and incidence of hypertension during follow-up according to parity
Parameter Nulliparous Parous P
N¼122 N¼878
Hypertension at baseline 34 (27.9%) 326 (37.1%) 0.046
Hypertension after FU 44 (36.1%) 404 (46.0%) 0.038
Incidence of hypertension 12 (9.8%) 97 (11.0%) 0.687
Subanalysis of initially normotensive women (N¼640)
N¼88 N¼552
Incidence of hypertension during FU 12 (13.6%) 97 (17.6%) 0.362
FU, follow-up.
TABLE 3. Univariate analysis for hypertension at baseline
Parameter OR 95% CI P
Age 1.040 1.015–1.065 0.001
Weight 1.043 1.032–1.054 <0.001
BMI 1.129 1.097–1.163 <0.001
Metabolic syndrome 19.764 11.429–34.178 <0.001
Diabetes 2.360 1.024–5.438 0.044
Parity 1.529 1.006–2.324 0.047
Menopause 1.049 0.753–1.462 0.777
HRT 0.865 0.663–1.127 0.282
Family history of
hypertension
2.848 2.120–3.826 <0.001
Family history of diabetes 0.926 0.703–1.218 0.581
Family history of CVD 1.306 0.971–1.757 0.077
Total cholesterol 1.000 0.997–1.004 0.961
LDL cholesterol 1.002 0.998–1.006 0.413
HDL cholesterol 0.969 0.959–0.980 <0.001
LDL/HDL cholesterol 1.423 1.202–1.684 <0.001
Triglycerides 1.009 1.006–1.012 <0.001
Blood glucose 1.017 1.006–1.027 0.001
Framingham risk score 1.650 1.478–1.842 <0.001
CVD, cardiovascular disease; HDL, high density lipoprotein; HRT, hormone replacement
therapy; LDL, low density lipoprotein.
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blood pressure from preconception to years after delivery.
It is well known that pregnancy leads to increased blood
volume and decrease in systemic vascular resistance,
together elevating utero-placental blood flow without com-
promising maternal circulation [5,6]. Thus, the issue is
whether these physiologic cardiovascular adaptations leave
a lasting imprint on arterial compliance and endothelial
function. Dhawan et al. [26] found greater pressure
responses to phenylephrine and acute stress in repeatedly
breed versus virgin rats and speculated that this augmented
response of multiparous rats may be ascribed to a greater
increase in total peripheral resistance. Indeed, they hypo-
thesized that repeated pregnancy may blunt the activity of
the vasodilatatory NO system and enhance the productions
of vasoconstrictive prostaglandins. Another study con-
ducted on female rats by Reckelhoff et al. [27] suggested
that pregnancy might leave the vessels with some degree of
endothelium damage, which could be responsible for sub-
sequent endothelium dysfunction. These evidences are
consistent with our results and also propose possible
mechanisms by which parity may be related with higher
prevalence of hypertension in later life. Our study has the
peculiarity of analysing the prevalence of hypertension
through menopausal transition, intended as a period of
potential vulnerability across women’s life span. Our main
findings suggest that the association between parity and
hypertension is already evident during menopausal tran-
sition and not after menopause. Conversely, when high
blood pressure develops after menopause, there is no
association with parity. It is the first time this relationship
between parity and hypertension has been investigated
specifically through menopausal transition and early
postmenopause. Several studies analyzed the impact of
childbearing on BMI and the incidence of the metabolic
syndrome. The Coronary Artery Risk Development in
Young Adults study showed that parity was associated with
future development of the metabolic syndrome independ-
ent of prior obesity and pregnancy-related weight gain [28].
Similarly, the Guangzhou Biobank Cohort Study stated that
higher parity was related to a consistent increase in the risk
of metabolic syndrome in Chinese women [14]. Given this
and considering that pregnancy may have detrimental
effects on fat distribution and insulin resistance, it might
be plausible that parity increases women’s risk of hyper-
tension in terms of higher BMI and incidence of the meta-
bolic syndrome. Despite this, in our population there is no
difference in terms of BMI in nulliparous versus parous
women. Indeed, the relationship between parity and
TABLE 4. Multivariate backward regression analysis for hypertension at baseline
Parameter OR 95% CI P
BMI 1.097 1.048–1.149 <0.001
Metabolic syndrome 17.252 7.057–42.178 <0.001
Diabetes 0.170 0.030–0.952 0.044
Parity 2.907 1.290–6.547 0.010
Family history of hypertension 3.623 2.231–5.883 <0.001
Family history of diabetes 0.547 0.340–0.880 0.013
Total cholesterol 0.952 0.929–0.975 <0.001
LDL cholesterol 1.034 1.011–1.059 0.004
HDL cholesterol 1.058 1.030–1.087 <0.001
Framingham risk score 1.945 1.651–2.290 <0.001
HDL, high density lipoprotein; LDL, low density lipoprotein.
Diabetes
Multivariate analysis
OR with 95% CI
0.0 0.5 1.0 1.5 2.0 5 7 50
Family history of diabetes
Family history of hypertension
Metabolic syndrome
Parity
Total cholesterol
LDL cholesterol
HDL cholesterol
BMI
Framingham risk score
FIGURE 1 Multivariate analysis for hypertension at baseline.
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hypertension remains significant after adjustment for other
confounding effects, especially BMI, and these evidences
refute the hypothesis that higher blood pressure among
parous women is due to a worse metabolic profile. More-
over, there are no differences regarding lipid and glucose
profile according to parity.
Demonstrating that parous women are at higher risk of
being hypertensive, our study also supports the hypothesis
that pregnancy may influence future cardiovascular risk
profile of the mother. Nevertheless, it is the first study
identifying this increased risk due to higher blood pressure.
In fact, other studies suggested adverse lipid profile and
diabetes as responsible for increased coronary heart disease
[8] or carotid artery plaques in elderly women [29].
Nulliparous women were more likely to be postmeno-
pausal at baseline and menopause occurs 2 years later
among women with at least one child: this is coherent with
the evidence that during pregnancy ovarian follicles are
preserved. Despite this difference in age at menopause
according to parity, no relation has been highlighted with
the prevalence of hypertension. Our study agrees with
those indicating no association between menopause and
hypertension and showing high blood pressure after men-
opause is due to increasing age and BMI [30].
Apart from parity, also traditional cardiovascular risk
factors such as metabolic syndrome, BMI and diabetes
showed an independent relationship with hypertension
at baseline. Family history of hypertension was found to
be the strongest predictor of estimated hypertension risk,
increasing it more than three-fold.
Our study has some limits. First of all, it is an observa-
tional study, only partially prospective; therefore, it is able
to provide associations, but not to prove a causal relation-
ship between parity and hypertension. This study design,
however, allow us to explore the specific issue of parity
impact across menopausal transition. As it is a retrospective
study, data regarding pregnancy-induced hypertension that
resolved with the end of pregnancy and gestational dia-
betes are lacking. On the contrary, we gathered data
regarding the age of hypertension development. Indeed,
in our database are reported cases of women who devel-
oped pregnancy-induced hypertension and remained
hypertensive after pregnancy. Moreover, we collected data
regarding previous hormonal replacement therapy and
the duration of treatment, although information about
the timing of treatment are lacking.
Although the majority of the studies analyzed SBP and
DBP levels, we took into consideration only hypertensive
or normotensive status. SBP and DBP, indeed, vary greatly
according to the time of the day and emotional status,
making the prevalence of hypertension a much more
reliable parameter. Hormonal measurements, such as
FSH, have not been performed. Hormone assays would
have been helpful for the identification of the stages of
reproductive aging and it would be appropriate and inter-
esting to investigate these parameters in the comparison
between groups. Nevertheless, biomarker criteria are only
supportive for identification of the stages of reproductive
aging [22] and considering that the main target of BenEssere
Donna Clinic is cardiovascular prevention, such tests are
not routinely performed, according to current guidelines
[31]. A limitation of our study is that marriage status has
not been taken into account, as well as data regarding the
age of the first pregnancy and whether parity was due to
choice or infertility. We did not take into account thyroid
function, although it is well known that any type of thyroid
dysfunction may reduce the likelihood of pregnancy, so
that it would be very interesting to investigate this issue in
relation with hypertension in future. Finally, a strength of
our study is the relatively large and homogeneous sample,
representative of a real-life population of women around
menopause, which are still underrepresented in clinical
trials [32].
In conclusion, parity is associated with early hyperten-
sion duringmenopausal transition in white perimenopausal
and postmenopausal women, so that women with at least
one child had almost three-fold risk of being already hyper-
tensive compared with nulliparous women. Conversely,
newly diagnosed hypertension after menopause is not
related with parity.
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Reviewer’s Summary Evaluations
Referee 1
Strengths: The results are based on a large-scale study and
describe a relatively novel finding, associating parity with
hypertension. Weaknesses: restrospective analysis based
on patient records, lack of information on possible con-
founders.
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